Search

Displaying results 7601 - 7610 of 7655 in total
  1. Drug

    PN0621

    go.drugbank.com/drugs/DB05218
    Experimental

    PN0621 is an anti-TNF, domain antibody (dAb) based therapeutic. It targets tumour necrosis factor (TNF) to treat auto-immune inflammatory diseases such as rheumatoid arthritis. It is being developed by Peptech.

  2. Drug

    Talabostat

    go.drugbank.com/drugs/DB06182
    Investigational

  3. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational

  4. Drug

    Benzquinamide

    go.drugbank.com/drugs/DB00767
    ApprovedWithdrawn

    Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine re...

  5. Drug

    Glufosfamide

    go.drugbank.com/drugs/DB06177
    Investigational

  6. Drug

    Darinaparsin

    go.drugbank.com/drugs/DB06179
    Investigational

  7. Drug

    Amdoxovir

    go.drugbank.com/drugs/DB06619
    Investigational

  8. Drug

    Enrasentan

    go.drugbank.com/drugs/DB06460
    Experimental

  9. Drug

    RDEA806

    go.drugbank.com/drugs/DB05228
    Investigational

    RDEA806 is a new HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity.

  10. Drug

    Tifuvirtide

    go.drugbank.com/drugs/DB05413
    Investigational

    Tifuvirtide is the first members of a new class of anti-HIV drugs which is also called fusion inhibitors. It has received fast-track designation from the FDA and is in Phase I/II clinical testing.